# Targeting Inter-Hemispheric Alpha Coherence With tACS To Treat PMDD

> **NCT02362191** · NA · TERMINATED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 5 (actual)

## Conditions studied

- Premenstrual Dysphoric Disorder

## Interventions

- **DEVICE:** Alternating Current Stimulator

## Key facts

- **NCT ID:** NCT02362191
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-03
- **Primary completion:** 2020-03
- **Final completion:** 2020-03
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** The study was terminated because the dense treatment schedule precluded successful recruitment of study participants.
- **Last updated:** 2020-10-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02362191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02362191, "Targeting Inter-Hemispheric Alpha Coherence With tACS To Treat PMDD". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02362191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*